Table 5.
Ala160Ala | Ala160Thr | Thr160Thr | |
---|---|---|---|
No. 191 | 90 (47%) | 83 (44%) | 18 (9%) |
Donor | |||
| |||
Age | 36 (21–47) | 35 (25–48) | 40 (24–44) |
Ethnicity | |||
Caucasian | 32 (36%) | 54 (65%) | 13 (72%) |
African American | 30 (33%) | 11 (13%) | 0 (0%) |
Hispanic | 18 (20%) | 16 (19%) | 4 (22%) |
Other | 10 (11%) | 2 (2%) | 1 (6%) |
Smoking | 22 (24%) | 32 (39%) | 8 (44%) |
Last pO2 | 453 (398–490) | 460 (141–512) | 415 (389–504) |
| |||
Recipient | |||
| |||
Age | 58 (43–62) | 57 (43–62) | 53 (36–60) |
Disease | |||
COPD | 24 (27%) | 24 (29%) | 8 (44%) |
ILD | 38 (42%) | 34 (41%) | 4 (22%) |
CF | 16 (18%) | 15 (18%) | 6 (33%) |
Other | 12 (13%) | 10 (12%) | 0 (0%) |
Bilateral lung-Tx | 66 (73%) | 59 (71%) | 16 (89%) |
CMV mismatch | 19 (32%) | 21 (20%) | 12 (43%) |
PGD-3 at 72 h | 8 (9%) | 6 (7%) | 2 (11%) |
PGD, primary graft dysfunction score. Numbers in brackets show 25th to 75th percentile range.